Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?

Annals of Surgery

Volumn 254, Issue 3, 2011, Pages 527-538

  Koniaris, Leonidas G ^a   Levi, David M ^a   Pedroso, Felipe E ^a   Franceschi, Dido ^a   Tzakis, Andreas G ^a   Santamaria Barria, Juan A ^a   Tang, Jennifer ^a   Anderson, Marissa ^a   Misra, Subhasis ^a   Solomon, Naveenraj L ^a   Jin, Xiaoling ^a   Dipasco, Peter J ^a   Byrne, Margaret M ^a   Zimmers, Teresa A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER PATIENT; CANCER SURVIVAL; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER LOBECTOMY; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL END STAGE LIVER DISEASE SCORE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; WEDGE RESECTION; CANCER RECURRENCE; OUTCOME ASSESSMENT; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; FLORIDA; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052301091     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822ca66f     Document Type: Conference Paper

References (40)

1. World Health Organization. Website: http://www.who.int/mediacentre/ factsheets/fs297/en/index.html. Accessed May 1, 2011.
2. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 suppl 1):S27-S34. (Pubitemid 39423367)
3. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5 suppl 1):S5-S16. (Pubitemid 39423365)
4. Bruno S, Silini E, Crosignani A, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology. 1997;25(3):754-758. (Pubitemid 27106466)
5. McKillop IH, MoranDM, JinX, et al. Molecular pathogenesis of hepatocellular carcinoma. J Surg Res. 2006;136(1):125-135. (Pubitemid 44634548)
6. Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011;253(3): 453-469. Review.
7. Earle SA, Perez EA, Gutierrez JC, et al. Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg. 2006;203(4):436-446. (Pubitemid 44416263)
8. Levi DM, Tzakis AG, Martin P, et al. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. J Am Coll Surg. 2010;210(5):727-734, 735-736.
9. Nguyen KT, Geller DA. Laparoscopic liver resection-current update. Surg Clin North Am. 2010;90(4):749-760.
10. Liang HH, Chen MS, Peng ZW, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol. 2008;15(12):3484-3493.
11. Raut CP, Izzo F, Marra P, et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005;12(8):616-628. (Pubitemid 41126091)
12. Mathur AK, Osborne NH, Lynch RJ, et al. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg. 2010;145(12):1158-1163.
13. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321-328. (Pubitemid 43327762)
14. Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252(6):903-912.
15. ShabahangM, Franceschi D, Yamashiki N, et al. Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol. 2002;9(9):881-886. (Pubitemid 35265639)
16. Koniaris LG, McKillop IH, Schwartz SI, et al. Liver regeneration. J Am Coll Surg. 2003;197(4):634-659. (Pubitemid 38223851)
17. Cherqui D, Laurent A, Mocellin N, et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg. 2009;250(5):738-746.
18. Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg. 2000;190(5):580-587. (Pubitemid 30230706)
19. Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl. 2003;9(5):513-520. (Pubitemid 36621722)
20. Margarit C, Escartin A, Castells L, et al.Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl. 2005;11(10):1242-1251. (Pubitemid 41511939)
21. Poon RT, Fan ST, Lo CM, et al. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg. 2007;245(1):51-58. (Pubitemid 46035435)
22. Shah SA, Cleary SP, Tan JC, et al. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol. 2007;14(9):2608-2614. (Pubitemid 47389575)
23. Facciuto ME, Rochon C, Pandey M, et al. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intentionto-treat analysis in patients within and outwith Milan criteria. HPB (Oxford). 2009;11(5):398-404.
24. Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 2003;238(6):885-892; discussion 892-893.
25. Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg. 2003;238(4):508-518; discussion 518-519.
26. Reddy SK, Tsung A, Geller DA. Laparoscopic liver resection. World J Surg. 2010;35(7):1478-1486.
27. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693-699. (Pubitemid 26079803)
28. Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007;7(11):2587-2596. (Pubitemid 47561609)
29. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33(6):1394-1403. (Pubitemid 32496976)
30. Jin X, Zhang Z, Beer-Stolz D, et al. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology. 2007;46(3):802-812. (Pubitemid 47436127)
31. Jin X, Zimmers TA, Perez EA, et al. Paradoxical effects of short-and long-term interleukin-6 exposure on liver injury and repair. Hepatology. 2006;43(3):474-484.
32. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470. (Pubitemid 32119037)
33. Goh A. An analysis of liver transplant survival rates from the UNOS registry. Clin Transpl. 2008:19-34.
34. Nathan H, Bridges JF, Schulick RD, et al. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol. 2011;29(6):619-625.
35. Jablonski EM,MattocksMA, Sokolov E, et al. Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma. Cancer Lett. 2007;250(1):36-46. (Pubitemid 46483843)
36. Moran DM, Mattocks MA, Cahill PA, et al. Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J Surg Res. 2008;147(1):23-33. (Pubitemid 351626069)
37. Moran DM, Koniaris LG, Jablonski EM, et al. Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression. Cell Transpl. 2006;15(8/9):785-798. (Pubitemid 46095261)
38. Zimmers TA, Jin X, Gutierrez JC, et al. Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol. 2008;134(7):753-759.
39. Price JA, Kovach SJ, Johnson T, et al. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology. 2002;36(5):1089-1097. (Pubitemid 35253424)
40. Cieply B, Zeng G, Proverbs-Singh T, et al. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology. 2009;49(3):821-831.